Clinical Trials Browser

INDUSTRY × Expanded_access × Ramucirumab × Clear all

NCT02065765 2025-01-09

International Expanded Access Program to Provide Ramucirumab for the Treatment of Metastatic Gastric Cancer

Approved for marketing

Gastrointestinal

Stomach Neoplasms